148 related articles for article (PubMed ID: 30093628)
21. Capicua controls Toll/IL-1 signaling targets independently of RTK regulation.
Papagianni A; Forés M; Shao W; He S; Koenecke N; Andreu MJ; Samper N; Paroush Z; González-Crespo S; Zeitlinger J; Jiménez G
Proc Natl Acad Sci U S A; 2018 Feb; 115(8):1807-1812. PubMed ID: 29432195
[TBL] [Abstract][Full Text] [Related]
22. ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.
Rousseaux MWC; Tschumperlin T; Lu HC; Lackey EP; Bondar VV; Wan YW; Tan Q; Adamski CJ; Friedrich J; Twaroski K; Chen W; Tolar J; Henzler C; Sharma A; Bajić A; Lin T; Duvick L; Liu Z; Sillitoe RV; Zoghbi HY; Orr HT
Neuron; 2018 Mar; 97(6):1235-1243.e5. PubMed ID: 29526553
[TBL] [Abstract][Full Text] [Related]
23. Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factors.
Ahmad ST; Rogers AD; Chen MJ; Dixit R; Adnani L; Frankiw LS; Lawn SO; Blough MD; Alshehri M; Wu W; Marra MA; Robbins SM; Cairncross JG; Schuurmans C; Chan JA
Nat Commun; 2019 May; 10(1):2000. PubMed ID: 31043608
[TBL] [Abstract][Full Text] [Related]
24. Capicua is a fast-acting transcriptional brake.
Patel AL; Zhang L; Keenan SE; Rushlow CA; Fradin C; Shvartsman SY
Curr Biol; 2021 Aug; 31(16):3639-3647.e5. PubMed ID: 34166605
[TBL] [Abstract][Full Text] [Related]
25. A double-edged sword: The world according to Capicua in cancer.
Tanaka M; Yoshimoto T; Nakamura T
Cancer Sci; 2017 Dec; 108(12):2319-2325. PubMed ID: 28985030
[TBL] [Abstract][Full Text] [Related]
26. Origins of context-dependent gene repression by capicua.
Forés M; Ajuria L; Samper N; Astigarraga S; Nieva C; Grossman R; González-Crespo S; Paroush Z; Jiménez G
PLoS Genet; 2015 Jan; 11(1):e1004902. PubMed ID: 25569482
[TBL] [Abstract][Full Text] [Related]
27. RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma.
Eleveld TF; Schild L; Koster J; Zwijnenburg DA; Alles LK; Ebus ME; Volckmann R; Tijtgat GA; van Sluis P; Versteeg R; Molenaar JJ
Cancer Res; 2018 Nov; 78(21):6297-6307. PubMed ID: 30115695
[TBL] [Abstract][Full Text] [Related]
28. Capicua restricts cancer stem cell-like properties in breast cancer cells.
Yoe J; Kim D; Kim S; Lee Y
Oncogene; 2020 Apr; 39(17):3489-3506. PubMed ID: 32108163
[TBL] [Abstract][Full Text] [Related]
29. The crystal structure of Capicua HMG-box domain complexed with the ETV5-DNA and its implications for Capicua-mediated cancers.
Lee H; Song JJ
FEBS J; 2019 Dec; 286(24):4951-4963. PubMed ID: 31323153
[TBL] [Abstract][Full Text] [Related]
30. CIC reduces xCT/SLC7A11 expression and glutamate release in glioma.
Park JW; Kilic O; Deo M; Jimenez-Cowell K; Demirdizen E; Kim H; Turcan Ş
Acta Neuropathol Commun; 2023 Jan; 11(1):13. PubMed ID: 36647117
[TBL] [Abstract][Full Text] [Related]
31. Capicua in Human Cancer.
Kim JW; Ponce RK; Okimoto RA
Trends Cancer; 2021 Jan; 7(1):77-86. PubMed ID: 32978089
[TBL] [Abstract][Full Text] [Related]
32. SRSF10 inhibits biogenesis of circ-ATXN1 to regulate glioma angiogenesis via miR-526b-3p/MMP2 pathway.
Liu X; Shen S; Zhu L; Su R; Zheng J; Ruan X; Shao L; Wang D; Yang C; Liu Y
J Exp Clin Cancer Res; 2020 Jun; 39(1):121. PubMed ID: 32600379
[TBL] [Abstract][Full Text] [Related]
33. CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas.
Gleize V; Alentorn A; Connen de Kérillis L; Labussière M; Nadaradjane AA; Mundwiller E; Ottolenghi C; Mangesius S; Rahimian A; Ducray F; ; Mokhtari K; Villa C; Sanson M
Ann Neurol; 2015 Sep; 78(3):355-74. PubMed ID: 26017892
[TBL] [Abstract][Full Text] [Related]
34. The Capicua repressor--a general sensor of RTK signaling in development and disease.
Jiménez G; Shvartsman SY; Paroush Z
J Cell Sci; 2012 Mar; 125(Pt 6):1383-91. PubMed ID: 22526417
[TBL] [Abstract][Full Text] [Related]
35. Impact of Capicua on Pancreatic Cancer Progression.
Yoshiya S; Itoh S; Yoshizumi T; Yugawa K; Kurihara T; Toshima T; Harada N; Hashisako M; Yonemasu H; Fukuzawa K; Oda Y; Mori M
Ann Surg Oncol; 2021 Jun; 28(6):3198-3207. PubMed ID: 33216264
[TBL] [Abstract][Full Text] [Related]
36. Capicua suppresses colorectal cancer progression via repression of ETV4 expression.
Lee JS; Kim E; Lee J; Kim D; Kim H; Kim CJ; Kim S; Jeong D; Lee Y
Cancer Cell Int; 2020; 20():42. PubMed ID: 32042269
[TBL] [Abstract][Full Text] [Related]
37. Negative MAPK-ERK regulation sustains CIC-DUX4 oncoprotein expression in undifferentiated sarcoma.
Lin YK; Wu W; Ponce RK; Kim JW; Okimoto RA
Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20776-20784. PubMed ID: 32788348
[TBL] [Abstract][Full Text] [Related]
38. Torso RTK controls Capicua degradation by changing its subcellular localization.
Grimm O; Sanchez Zini V; Kim Y; Casanova J; Shvartsman SY; Wieschaus E
Development; 2012 Nov; 139(21):3962-8. PubMed ID: 23048183
[TBL] [Abstract][Full Text] [Related]
39. Structural basis of the phosphorylation dependent complex formation of neurodegenerative disease protein Ataxin-1 and RBM17.
Kim E; Lee Y; Choi S; Song JJ
Biochem Biophys Res Commun; 2014 Jul; 449(4):399-404. PubMed ID: 24858692
[TBL] [Abstract][Full Text] [Related]
40. Kinetics of gene derepression by ERK signaling.
Lim B; Samper N; Lu H; Rushlow C; Jiménez G; Shvartsman SY
Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10330-5. PubMed ID: 23733957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
